Pharmacologically inhibition of autophagy by HCQ/wortmannin inhibits propionate‐induced autophagy in vitro, and HCQ treatment ameliorates obesity, hepatic steatosis and insulin resistance of the Acss3–/– mice in vivo. Here, ACSS3 is linked to obesity disorder.